Results 251 to 260 of about 44,151 (306)

Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study. [PDF]

BMC Cardiovasc Disord
Hassen M, Ebsa TK, Muhammed OS, Solomon T, Demessie MB, Wendie TF, Tesfaye NA, Gobezie MY.   +7 more
europepmc   +1 more source

Correspondence to editorial on "Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)". [PDF]

Clin Mol Hepatol
Liu C, Yang L, You H, Teng GJ, Qi X.
europepmc   +1 more source

Management of patient with acute lymphocytic myocarditis and congenital long QT syndrome presenting with electrical storm and incessant Torsade de Pointes: a case report. [PDF]

J Med Case Rep
Karwiky G, Pranata R, Undarsa AC, Iqbal M, Prameswari HS, Akbar MR.   +5 more
europepmc   +1 more source

The SARAH trial: more evidence on the role of neurohormonal blockers in prevention of anthracycline-induced cardiotoxicity. [PDF]

Heart Fail Rev
Mecinaj A, Vinje-Jakobsen V, Ngo DTM, Sverdlov AL, Myhre PL.   +4 more
europepmc   +1 more source

Pharmacological Treatment of Ascites: Challenges and Controversies. [PDF]

Pharmaceuticals (Basel)
Lai JC, Dai J, Liang LY, Wong GL, Wong VW, Yip TC.   +5 more
europepmc   +1 more source

The Role of Radiosensitizing Drugs in Osteosarcoma Treatment: Mechanisms and Clinical Perspectives. [PDF]

Drug Des Devel Ther
Zhang Y, Xie Y, Wang Y, Huang P, Lu Y.
europepmc   +1 more source

A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2). [PDF]

Cardiooncology
Gong FF, Grunblatt E, Voss WB, Rangarajan V, Raissi S, Chow K, Jafari L, Patel NP, Vaitenas I, Marion M, Ramirez H, Zhao M, Andrei AC, Baldridge AS, Murtagh G, Maganti K, Rigolin VH, Akhter N.   +17 more
europepmc   +1 more source

Visualizing global progress and challenges in esophagogastric variceal bleeding. [PDF]

World J Gastrointest Surg
Wang DX, Wu XJ, Yu JZ, Zhan JY, Xing FF, Liu W, Chen JM, Liu P, Liu CH, Mu YP.   +9 more
europepmc   +1 more source

From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on "Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)". [PDF]

Clin Mol Hepatol
Deshmukh A, Maiwall R.
europepmc   +1 more source